The effect of N-methyl-D-aspartate (NMDA) and 2-(aminomethyl)phenylacetic acid/kainate (AMPA/kainate) glutamate receptors on dentate cell proliferation and hippocam pal synapsin-l induction was examined after global ischemia. Cell proliferation was assessed using BrdU labeling, and syn aptic responses were assessed using synapsin-I expression, Sys temic glutamate receptor antagonists (MK-80 l and NBQX) in creased BrdU-labeled cells in the dentate subgranular zone (SGZ) of control adult gerbils (30% to 90%, P < 0.05). After global ischemia (at 15 days after 10 minutes of ischemia), most CA l pyramidal neurons died, whereas the numbers of BrdU labeled cells in the SGZ increased dramatically (>1000%, P < 0,0001). Systemic injections of MK801 or NBQX, as well as intrahippocampal injections of either drug. when given at the time of ischemia completely blocked the birth of cells in the SGZ and the death of CA 1 pyramidal neurons at J 5 days after ischemia. Glutamate receptor antagonists had little effect on Transient global cerebral ischemia causes selective cell death in vulnerable regions. It produces cell injury and death in the hippocampus of gerbils, rats, primates, and humans, with prominent injury to hippocampal CA 1 pyramidal neurons and dentate hilar neurons (Hsu and Buzsaki, 1993; Gonzalez et a1 ., 1991; Ito et a!., 1975; Kirino, 1982; Westerberg et aI., 1989; Herguido et aI., 1999). This ischemic hippocampal injury results in an terograde and retrograde recent memory loss in animals and man (Squire and Zola-Morgan, 1996; Zola-Morgan et aI., 1992). Neuronal damage that follows ischemia appears to involve overstimulation of glutamate recep tors, with the influx of Na+ and Ca 2 + ions through the
cell birth and death when administered 7 days after ischemia. The induction of synapsin-I protein in stratum moleculare of CA3 at 7 and J 5 days after global ischemia was blocked by pretreatment with systemic or intrahippocampaJ MK-801 or NBQX. It is proposed that decreased dentate glutamate receptor activation-produced by glutamate receptor antagonists in nor mal animals and by chronic ischemic hippocampal injury may trigger dentate neurogenesis and synaptogenesis. The syn apsin-I induction in mossy fiber terminals most likely repre sents re-modeling of dentate granule cell neuron presynaptic elements in CA3 in response to the ischemia. The den tate neurogenesis and synaptogenesis that occur after ischemia may contribute to memory recovery after hippocampal injury caused by global ischemia. Key Words: Neurogenesis Synaptogenesis-Global ischemia-Glutamate-NMDA AMPA-Recent memory-Hippocampus. channels gated by these receptors (Gill and Woodruff, 1990; Westerberg et aI., 1989) . N-methyl-D-aspartate re ceptor (NMDAR) and 2-(aminomethyl)phenylacetic acid/kainate receptor (AMP AlKAR) antagonists protect hippocampal CA 1 pyramidal neurons from delayed death after global ischemia in rodents (Simon et aI., 1984; Sheardown et aI., 1990; Buchan et aI., 1991 b; Gorter et aI., 1997; Colbourne et aI., 1999; Hicks et aI., 1999) , though NMDA R antagonists are much less effec tive (Hicks et aI., 1999) .
Recently, global ischemia has been found to stimulate the birth of new neurons in the adult brain (Liu et aI., 1998) . Most neurons of the mammalian adult nervous system are terminally differentiated (Gage et aI., 1998; Gage, 1998) . However, some cells continue to divide throughout life in the adult subventricular zone (SYZ) and subgranular zone (SGZ) of the dentate gyrus. Divid ing stem and progenitor cells have been described in the SGZ of rats, mice, primates, and humans (Altman and Das, 1965; Gage et aI., 1998; McKay, 1997) . Subgranular zone stem cells give rise to progenitor cells that prolif erate, migrate into the granule cell layer, and differenti ate into mature granule cell neurons. Many fac tors affect dentate neurogenesis, including age, enriched environments, and stress (Gage et aI., 1998; Cameron et al., 1998) . Not only does the NMDA R modulate neurogenesis during brain development (Gould et al., 1994) , but NMDAR blockade also increases the num ber of granular neuron precursors in adult brain (Cam eron et aI., 1995; Gould et aI., 1997) . Because gluta mate receptors mediate ischemic injury and ischemia induces neurogenesis, the authors examined the role NMDA and AMP A/KA receptors in ischemia-induced neurogenesis.
A significant proportion of the cells born in the SGZ after ischemia mature into granule cell neurons (Liu et aI., 1998) , some of which extend axons to the CA3 re gion of hippocampus (Stanfield and Trice, 1988; Markakis and Gage, 1999) . To study these synaptic re sponses, the authors determined whether synapsin-I, which is induced after ischemia (Marti et aI., 1999) , was induced during the period of neurogenesis and whether synapsin induction was modulated by NMDA or AMPAI kainate glutamate receptors. The results indicate that NMDA and AMP A/kainate receptor antagonists prevent the dentate neurogenesis and the dentate granule cell neuron synaptic responses that ordinarily occur after global ischemia. This data could suggest that NMDA and AMP Alkainate receptors mediate neurogenesis and syn aptogenesis after global ischemia or that prevention of cell death with glutamate receptor antagonists prevents neurogenesis and synaptogenesis after global ischemia, or both. Because neurogenesis occurs after blockade of hippocampal glutamate receptors in normal animals, the authors hypothesize that global ischemia !cads to chronic down-regulation of hippocampal glutamate receptors that stimulates neurogenesis and synaptogenesis. Conse quently, the authors propose that glutamate receptor an tagonists prevent neurogenesis and synaptogenesis after global ischemia by preventing hippocampal neuronal cell death and the chronic down-regulation of glutamate receptors.
MATERIALS AND METHODS

Animals
All studies were perfonned with adult male Mongolian ger bils (ll -to 13-weeks-old; Simmenson, Gilroy, CA, U.S.A.). Animal studies were performed according to National Institutes of Health guidelines under an approved local protocol from the San Francisco VA Medical Center. Gerbils were housed singly upon arrival to the authors' animal care facility and were ac climated to the new environment for at least one week before surgery. The colony was maintained on a 12-hour light-dark period at 23°C. Food and water were available ad libitum. 
Transient global ischemia
Animals were anesthetized with 3% isotlurane in 30% O2:70% N2• After bilateral neck incisions, both common ca rotid arteries were exposed and occluded with aneurysm clips for 10 minutes. Clips then were removed to restore cerebral blood flow. Animal temperatures were maintained at 37.5°C ± 0.5°C with a heating blanket connected with a rectal thermom eter until animals recovered from surgery. Sham-operated ani mals were treated similarly, except that the carotids were not occluded after the neck incisions.
Glutamate receptor antagonist administration
Two different glutamate receptor antagonists were used: MK-SOI (3 mg/kg; RBI labs; an NMDAR antagonist) and NBQX (30 mg/kg; RBI Labs; an AMPA/kainate R antagonist). NBQX blocks GluR 1-4 of the AMPA receptors, and GluR5-6 of the kainate receptors (Chittajallu et aI., 1999) . MK-801 was administered intraperitoneally three times-the first injection was 30 minutes before surgery, the second was 6 hours after ischemia, and the third was 24 hours after ischemia (Gill and Woodruff, 1990) . NBQX also was administered three times the first injection was 10 minutes before the carotid clamps were placed, the second was 6 hours after ischemia, and the third was 36 hours after ischemia. These schedules were chosen because they have been reported to protect CA 1 pyramidal neurons after global ischemia (Sheardown et aI., 1990; Diemer et aI., 1992) . Control animals were injected on the same sched ules, except that saline (sterile 0.9% NaCl) was injected. Nine days after the ischemia, BrdU (50 mg/kg) was administered intraperitoneally daily for 4 days. BrdU was administered on days 9 to 12 because this is the period of maximal cell prolif eration after global ischemia in the gerbil brain (Liu et aI., 1995) . Animals were killed 15 days after the ischemia.
A second group of gerbils was submitted to the same global ischemic injury described for the first group. However, the drugs were not injected until day 7 after ischemia when MKSOI (3 mg/kg, IP), NBQX (30 mg/kg, IP), or saline (0.9%, same volume IP) were injected on the same schedule (time 0, 6 and 24, or 36 hours) as the first group. The delay of 7 days was used because this is just before the period of neurogenesis that oc curs after global ischemia (Liu et aI., 1995) . Nine days after the ischemia, BrdU (50 mg/kg) was administrated IP daily for 4 days (days 9 to 12 after ischemia) as in all of the groups.
A third group of gerbils served as drug-injected controls that is, they were subjected to sham operations without isch emia and had glutamate antagonists or saline injected on the same schedule as the first group. Nine days after the sham surgery, BrdU (50 mg/kg) was administered intraperitoneally daily for 4 days (9 to 12 days after sham surgery). Animals were killed 15 days after sham surgery (control MK-S01, con trol NBQX, saline control).
Microinjection of NMDA and AMPAlkainate receptor antagonists into CAl
Gerbils were anesthetized with 3% isoflurane in 30% O2:70% N2 and placed in a rodent stereotaxic. The skin over the skull was incised and bilateral burr holes were drilled manually. Needles were inserted through the burr holes and bilateral mi croinjections of either MKSOI (0.5 J-LL in each side, 3 J-Lg/J-LL solution) or NBQX (0.5 J-LL in each side, 30 J-Lg/J-LL solution) were perfonned using a Hamilton syringe (I J-LL, 30 g needle; Hamilton, Reno, NV, U.S.A.). The target for the injections was the CA I area of the dorsal hippocampus at coordinates A: 2.S; L: 1.9; V: 1.1. Even though the targeted region was CA l, it is likely that the injections spread to dorsal and ventral hippo campus, including CA 1, CA3, the dentate gyrus, and the SGZ.
BrdU labeling
The thymidine analog BrdU (5-bromo-2' -deoxyuridine-5' monophosphate) was administered intraperitoneally (50 mg/kg, Sigma, St. Louis, MO, U.S.A.) once daily for 4 consecutive days during the peak of cell proliferation, 9 to 12 days after ischemia (Liu et aI., 1998) . BrdU appeared to only label divid ing cells, because there was never any BrdU incorporation into CAl neurons or any other dying cell that might be undergoing some degree of DNA repair (Liu et a!., 1998) . All animals were killed at 15 days after ischemia. Nonischemic animals were injected with BrdU for 4 consecutive days on days 9 to 12 after sham surgeries and then killed 3 days later on day 15.
Immunohistochemistry
Gerbils were anesthetized with ketamine (80 mg/kg; Parke Davis, Morris Plains, NJ. U.S.A.) and xylazine (20 mg/kg; Buther, Columbus, OH, U.S.A.). They were perfused transcar dially with 0.9% saline, followed by 4% paraformaldehyde in 0.1 mM phosphate-buffered saline (PBS) (pH: 7.4). Brains were removed, postfixed for 6 hours in 4% paraformaldehyde PBS, and placed overnight in 20% sucrose. Coronal frozen sections (45-J.Lm-thick) were cut on a microtome and stored in PBS with azide (0.1 %). To detect BrdU-Iabeled nuclei using immunocytochemistry, DNA was denatured to expose the an tigen by treatment with 2N HCI for 30 minutes at 37°C. After rinsing twice in 0.1 mM PBS, sections then were incubated overnight at 4°C with the primary antibody to BrdU (11500, Boehringer Mannheim) in PBS with I % normal serum, 0.1 % bovine serum albumin, and 0.3% triton X-I OO. NeuN (1/500, Sigma) immunocytochemistry was used to evaluate the pres ence or absence of neuronal nuclei (Liu et aI., 1998) , and syn apsin-I (1/800, Stressgen, Victoria, BC, Canada) immunohis tochemistry was performed to evaluate the presynaptic protein response to ischemic injury. The same protocol used for BrdU was used for these antibodies, except that the DNA denatur ation procedure was deleted.
Western blotting
Total protein was extracted from the hippocampal CA3 sub region and Western blot analysis was performed as described previously (Melloni et aI., 1993) . Brietly, gerbil brains from the different groups were frozen at -80°C. Slices (300-J.Lm-thick) were cut on a cryostat, followed by microdisection of CA3 under a microscope. Four brains for each condition were used. Tissue was homogenized in I mL of Laemmli buffer. Proteins were separated by sodium dodecyl sulphate-polyacrylamide gel electrophoresis and transferred to polyvinylidenetluoride mem branes, and blots were incubated in blocking solution contain ing 3% bovine serum albumin in 0.1 mollL PBS, 0.1 o/i.' Tween 20, and 3% normal serum. Primary antibody against syanpsin-I (1/500, Stressgen) was diluted in this same buffer and hybrid ized to blots overnight. Bands were visualized using ECL ac cording to the manufacturer's specifications (Amersham, Ar lington Heights, IL, U.S.A.).
Cell counting
The number of BrdU immunoreactive nuclei in each dentate gyrus (DO) was counted on 6 to 9 coronal hippocampal sec tions (45-J.Lm-thick) per animal. Sections were spaced 180 J.Lm apart and spanned the entire dorsal hippocampus. Each micro scope image was digitized. BrdU-labeled nuclei were counted on a digital analysis system using National Institutes of Health v1.6 software (NIH 1.6 image program). The one focal plane per section that yielded the most nuclei was used to avoid oversampling. The density of BrdU immunoreactive cells in each scction was calculated by dividing the number of BrdU-positive nuclei by the area of the DO (in mm 2 ). These valucs were averaged to obtain a mean density value of BrdU-positive cells per mm 2 for each subject. Differences between the mean values from each treatment group were analyzed using Krustal Wallis analysis of variance followed by Neuman-Keuls test (SigmaStat: landel Scientific, San Rafael, CA, U.S.A.).
RESULTS
CAl neurons are protected by systemic and local hippocampal injections of MK-801
Control, saline-injected animals ( Fig. lA) and control, MK-80 1-injected animals ( Fig. lB) (injected IP 30 min utes before, 6 and 24 hours after ischemia) showed simi lar numbers of NeuN-immunostained neurons in CAl and DG. Bilateral carotid artery occlusions (l0 minutes in duration) resulted in severe loss of NeuN-stained CA I neurons in hippocampus 15 days after ischemia ( Fig. lC and IH). Systemic injections of MK80l (injected IP 30 minutes before, 6 and 24 hours after ischemia) prevented the CA 1 neuronal cell death 15 days after ischemia (Fig. ID). Injection of MK80 1 at 7 days after ischemia, 2 days before the increased neurogenesis in the dentate gyrus (Liu et aI., 1998) , did not prevent the loss of the CA 1 pyramidal neurons at 15 days after ischemia (Fig. IE) . These results confirm many previous studies that dem onstrate that a majority of the CAl neurons die and dis appear sometime between 2 and 5 days after global isch emia (using 10-minute carotid occlusions in the gerbil model), although cell death can continue for 2 weeks or more in some models (Colbourne et aI., 1999) . Animals microinjected with saline in the CAl hippocampal sub field showed the typical loss of CA l neurons 15 days after ischemia ( Fig. IF) . Remarkably, animals microin jected just one time in CAl with MK-80 1 at 30 minutes before ischemia demonstrated nearly complete preserva tion and neuroprotection of CAl neurons 15 days after ischemia ( Fig. 1 G) .
MK801 blocks the cell proliferation that occurs in dentate gyrus
To evaluate cell proliferation in the DG, BrdU was injected between 9 and 12 days after ischemia (when there is a maximal granular cell proliferation) or for 4 consecutive days in control, nonischemic animals. Ani mals were killed 15 days after surgery, 3 days after the last BrdU injection. There was a basal level of BrdU incorporation into newborn cells in the SGZ of the DG and in the SVZ (not shown) in the control animals ( Fig.  2A ). This is similar to the findings obtained using 3 H thymidine in previous studies (Cameron et al., 1995; Kaplan and Hinds, 1977; Stanfield and Trice, 1988) . MK-80 1 injected systemically (IP) into control animals significantly increased the number of BrdU-labeled cells ( Fig. 2B and SA); these results agree with previous stud ies (Cameron et aI., 1995) . At IS days after global isch emia, BrdU incorporation into cells in the dentate was in the CA 1 region of hippocampus and the granule cell layer of dentate gyrus (OG). Global ischemia (10 minutes) resulted in death of most CA1 pyramidal neurons 15 days later (C and H). Pre-and posttreatment with MK-801 (3 mg/kg, IP) protected CA1 neurons at 15 days after global ischemia (0 and I). Treatment with MK-801 at 7 days did not protect CA 1 neurons at 15 days after global ischemia (E). Hippocampal injections of saline before ischemia did not protect CA1 neurons (F), whereas hippocampal injections of MK-801 before ischemia did protect CA1 neurons at 15 days after global ischemia (G). Scale bar = 200 �m (A to G). significantly increased (Figs. 2C and 5A), in a pattern previously described for newborn cells in DG after isch emia in gerbils (Liu et aI., 1998) . Systemic injections of MK80 I (30 minutes before ischemia, and 6 and 24 hours after ischemia) completely blocked BrdU incorporation into DG cells (Fig. 2D) , with the number of BrDU labeled cells similar to those in control animals ( Fig. 5A , C vs. MO). Moreover, systemic injections of MK-80 1 given after the period of CAl neuronal loss, but before the neurogenesis increase (7 days after ischemia), had no effect on the marked increase of BrdU into cells in the DG at 9 to 12 days after ischemia ( Figs. 2E and 5A ). The numbers of BrdU-labeled cells were similar in the isch emia group and the ischemia group that received MK80 1 systemically 7 days after ischemia ( Fig. 5A, I MK-801 prevents the neuro genesis that occurs in dentate gyrus after ischemia. BrdU (50 mg/kg, IP) was administrated on days 9 to 12 af ter global ischemia (10 minutes) or for 4 consecutive days after sham sur gery in controls. All subjects were killed 15 days after ischemia. Panels A to I show BrdU-labeled cells in co ronal sections of hippocampus: h, dentate hilus; gcl, granule cell layer of dentate gyrus; and m, molecular layer of dentate gyrus. CAl neurons in hippocampus IS days after ischemia (Fig. 3C ). Systemic injections of NBQX (injected IP 30 minutes before. and 6 and 36 hours after ischemia) pre vented the CAl neuronal cell death IS days after isch emia (Fig. 3D) . The NBQX neuroprotection of CAl py ramidal cells was similar to that observed by others (Sheardown et al.. 1990; Diemer et al.. 1992; . Injection of NBQX at 7 days after ischemia. 2 days before the increased neurogenesis in the DG (Liu et al.. 1998) . did not prevent the loss of the CA I pyramidal neurons at IS days after ischemia (Fig. 3E ). Animals microinjected with saline in the CAl hippocampal sub field showed the typical loss of CA 1 neurons IS days after ischemia (Fig. IF) . However. animals microinjected with just one dose of NBQX in CA 1 at 30 minutes before ischemia demonstrated nearly complete preservation and neuroprotection of CAl neurons (Fig. 3F) .
NBQX blocks the cell proliferation and neurogenesis that occurs in dentate gyrus
To repeat the evaluation of cell proliferation and neu rogenesis in the DG. BrdU was injected between 9 and 12 days after ischemia or for 4 consecutive days in con-
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< " trol, nonischemic animals. Animals were killed IS days after surgery, 3 days after the last BrdU injection. There was a basal level of BrdU incorporation into newborn cells in the SGZ of the DG and in the SVZ (not shown) of the control animals ( Fig. 4A ). NBQX injected sys temically (rp) into control animals produced a modest increase in the number of BrdU-labeled cells (Figs. 4C and SB) . At IS days after global ischemia, BrdU incor poration into cells in the dentate was significantly in creased (Figs. 4B, 4H. and SB). Systemic injections of NBQX (30 minutes before. and 6 and 36 hours after ischemia) completely blocked BrdU incorporation into DG cells ( Fig. 4D and 41) , with the numbers of BrdU labeled cells similar to those in control animals (Fig. SB) . Moreover, systemic injections of NBQX given after the period of CA I neuronal loss, but before the neurogenesis increase (7 days after ischemia), had little effect on the marked increase of BrdU into cells in the DG at 9 to 12 days after ischemia (Figs. 4E and SB-N7). The number of BrdU-Iabeled cells was similar in the ischemia group (I) and the ischemia group that received NBQX systemi cally (N7) at 7 days after ischemia (Fig. SB) .
To evaluate where NBQX acts, local injections were made into hippocampus. Saline microinjected into CA 1 at 30 minutes before ischemia (Fig. 4F) pyramidal neurons 15 days later (C). Pre-and posttreatment with NBQX (30 mg/kg, IP) protected CA 1 neurons at 15 days after global ischemia (0). Hippocampal injections of saline before ischemia did not protect CA 1 neurons (E), whereas hippocampal injections of NBQX before ischemia did protect CA1 neurons at 15 days after global ischemia (F). Scale bar = 200 �m.
4F and 5B-S) compared with ischemic, noninjected ani mals (Figs. 4B and 5B to 51). However, microinjections of NBQX into CAl of hippocampus ( Fig. 4G and 5B Nh) at 30 minutes before ischemia produced a significant decrease of BrdU labeling at 15 days after ischemia (P < 0.001, in comparison with saline microinjection, Fig.  5B ). Notably, BrdU labeling in animals injected with NBQX into hippocampus of ischemic animals (Figs. 4G and 5B) was the same or even slightly lower than in control animals (Figs. 4A and 5B).
Glutamate receptor antagonists block the increased CA3 synapsin·I expression
Synapsin-I immunoreactivity was observed as a fine reticular staining in the neuropil of the plexiform layers of the hippocampus (Figs. 6 and 7) . Granule cell mossy fiber nerve terminals in the stratum lucidum layer of CA3 were particularly well stained compared with other portions of the hippocampus in control animals (Figs. 6A and 7 A). Western blots confirmed the presence of syn apsin-I in CA3 of hippocampus of control animals (Fig.  6H, lane B and Fig. 7H, lane B) . In addition, adminis tration of either MK-80 1 (Fig. 6H, lane C) or NBQX (Fig. 7H, lane C) Systemic administration of MK801 (30 minutes be fore, and 6 and 24 hours after ischemia) markedly de creased the induction of synapsin-I in CA3 at 15 days after ischemia as assessed using immunocytochemistry ( Fig. 6D ) and Western blotting (Fig. 6H , lane E). Sys temic administration of MK-801 at 7 days after ischemia had little effect on the marked induction of synapsin-I in CA3 ( Fig. 6E and 6H ) when compared with ischemia alone either by immunocytochemistry (compare Fig. 6E with Fig. 6B and 6C ) or by Western blotting (compare Fig. 6H, lanes D and F) .
Systemic administration of NBQX (10 minutes before, and 6 and 36 hours after ischemia) markedly decreased the induction of synapsin-I in CA3 at 15 days after isch emia as assessed using immunocytochemistry ( Fig. 7D ) and Western blotting (Fig. 7H, lane E) . Systemic admin istration of NBQX at 7 days after ischemia had little effect on the marked induction of synapsin-I in CA3 ( Fig. 7E and 7H ) when compared with ischemia alone either by immunocytochemistry (compare Fig. 7E with Fig. 7B and 7C ) or by Western blotting (compare Fig.  7H, lanes D and F) .
The next experiments determined whether MK-801 and NBQX act on hippocampus. Saline injections into hippocampus slightly decreased synapsin-I staining in FIG. 4. NBQX prevents the neuro genesis that occurs in dentate gyrus after ischemia. BrdU (50 mg/kg, IP) was administrated on days 9 to 12 af ter global ischemia (10 minutes) or for 4 consecutive days in controls. All subjects were killed 15 days after ischemia. Panels A to 1 show BrdU labeled cells in the coronal sections of hippocampus: h, dentate hilus; gcl, granule cell layer of dentate gyrus; and m, molecular layer of dentate gy .: .' � ...
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CA3 of hippocampus (Figs. 6F and 7F) when compared with ischemia ( Figs. 6C and 7C ), but the staining was still greater than in controls ( Fig. 7 A) . Remarkably, single injections into hippocampus of either MK-801 ( Fig. 6G) or NBQX (Fig. 7G ) 30 minutes before isch emia completely blocked the increased expression of synapsin-I protein in CA3 of hippocampus on immuno cytochemically-stained sections (Figs. 6G and 7G) and Western blots (Fig. 6H, lane E; Fig. 7H, lane E) .
Notably, systemic injections of MK-801 slightly de creased synapsin-I in CA3 compared with control ani mals (Fig. 6H, lane C compared with lane B) . In addi tion, systemic injections of NBQX also slightly de creased synapsin-I in CA3 compared with control animals (Fig. 7H, lane C compared with lane B) . These data suggest that baseline levels of synapsin in CA3 may be regulated by the activity of NMDA and AMPA/ kainate glutamate receptors even in normal control animals. 
DISCUSSION
Results
••
neuronal cell death, dentate cell proliferation, and the induction of synapsin-I protein that occur in hippocam pus after global ischemia. The results are consistent with the possibilities that NMD A and AMP Alkainate recep tors modulate neurogenesis, or that injuries that decrease dentate glutamate receptor activation stimulate dentate stem cell proliferation, or both. It is postulated that pre venting CA l cell death after ischemia with MK-80 l and NBQX may prevent glutamate receptor down-regulation in CAl and dentate (Gorter et aI, 1997; Aronica et ai, 1998) , thereby preventing hippocampal neurogenesis.
Systemic administration of an NMDA R antagonist, MK-80 1, to control animals stimulated cell proliferation in DG in the current study. This supports other studies that show that MK-80 I stimulates dentate precursor cell proliferation, with BrdU-labeled newborn cells develop ing into neurons and some into astrocytes (Gould et aI., 1994 (Gould et aI., , 1997 Cameron et aI., 1995 Cameron et aI., , 1998 . Notably, in studies by Gould et a!., (1977) , MK-801 1ed to changes in cell proliferation within hours of drug administration, whereas the current study demonstrated similar changes many days later. These studies suggest that even tempo rary blockade of NMDA receptors may alter dentate cell proliferation for several days. The current study also daily with BrdU for 4 days between 9 and 12 days after ischemia, and killed at 15 days after ischemia (3 days after the last injection of BrdU). (A) Number of BrdU-labeled cells in the dentate subgranular zone (SGZ) in control animals or ischemic animals given MK-801. Nonischemic animals given MK-801 had significantly more cells than animals given saline (e). After ischemia there was a marked increase in the number of BrdU-labeled cells (I) compared with controls (e). Treatment with MK-801 before and after ischemia (MO) decreased the number of BrdU-labeled cells compared with control (C) levels. However, large numbers of BrdU-labeled cells were observed in dentate when MK-801 was administered at ? days after ischemia (M?). Injection of saline into hippocampus before ischemia had no effect on the increased number of BrdU-labeled cells in dentate produced by ischemia (Sh). However, injection of MK-801 into hippocampus (Mh) before ischemia prevented the cell proliferation (Mh) normally produced by ischemia (I, Sh). (8) Number of BrdU labeled cells in the dentate SGZ in control animals or ischemic animals given NBQX. Nonischemic animals given NBQX (IP) had significantly more cells than animals given saline (C). After ischemia (I) there was a marked increase in the number of BrdU-labeled cells (I) compared with controls (e). Treatment with NBQX (NO) before and after ischemia decreased the number of BrdU-labeled cells compared with control (e) levels. However, large numbers of BrdU-labeled cells were observed in dentate when NBQX was administered at ? days after ischemia (N?). Injection of saline into hippocampus before ischemia had no effect on the increased number of BrdU-labeled cells in dentate produced by ischemia (Sh). However, injection of NSQX into hippocampus (Nh) before ischemia prevented the cell proliferation (Nh) normally produced by ischemia (I, Sh). Histogram bars indicate group mean values ± SD. * P < 0.05; ** P < 0.01; *** P < 0.001, using Student's Newman-Keuls test after analysis of variance, indicate significant differences induced by ischemia.
shows that the AMPA/KAR antagonist, NBQX, increases proliferation of dentate progenitor cells in nonnal brain, and suggests that in the normal, intact brain decreased glutamate activation of either NMDAR or AMP A/KAR increases dentate cell proliferation. This is consistent with cell culture studies that show that cell depolariza tion generally decreases DNA synthesis (Cui and Bulleit, 1998; LoTurco et aI., 1995) . Therefore, it was surprising that administration of ei ther MK-801 or NBQX blocked the neurogenesis that occurs after global ischemia. Ischemia should acutely stimulate NMDAR and AMPNKAR because there is glu tamate release during ischemia (Meldrum, 1995; Peruche and Krieglstein, 1993) and glutamate receptor antago nists prevent injury (Buchan et aI., 1991 b; Diemer et aI., 1992; Gill and Woodruff, 1990; Lippert et aI., ] 994; Sheardown et aI., 1990; Simon et aI., 1984) . The pilo carpine-induced seizures that stimulate neurogenesis (Parent et aI., 1997) also would be expected to increase glutamate release and acutely activate NMDA and AMPAlkainate glutamate receptors. Although ischemia and seizure activation of glutamate receptors may in crease neurogenesis, it is difficult to understand why glu tamate receptor antagonists also induce neurogenesis in control animals. It seems likely, therefore, that ischemia and seizure-induced neurogenesis occurs through some J Cereb Blood Flow Metab. Vol. 20. No. 12, 2000 other mechanism other than stimulating glutamate receptors.
Ischemia, seizures, and glutamate antagonists may all increase neurogenesis because there is decreased activa tion or down-regulation of hippocampal glutamate recep tors after hippocampal injuries of any type (Gorter et ai, 1997) ; that is, both NMDA and AMPA/kainate recep tors may continuously modulate neurogenesis in the den tate. After global ischemia (Liu et aI., 1998) there is death of CAl pyramidal neurons, dentate hilar neurons, and some CA3 neurons and dentate granule cell neurons (Fukuda et aI., 1999; Hsu and Buzsaki, 1993; Li et aI., 1997; Onodera et aI., 1990 Onodera et aI., , 1993 Sugimoto et aI., 1993) . Although ischemia acutely activates glutamate receptors, this cell death chronically decreases cell firing in all hippocampal circuits, decreasing the activity of dentate granule cell neurons and hippocampal CA3 and CAl neurons (Aoyagi et aI., 1998; Gao et aI., 1998; Howard et aI., 1998; Doherty and Dingledine, 1998) . In addition, there is down-regulation of NMDA and AMPAlkainate receptors after ischemia in CAl and to some degree in dentate (Pellegrini-Giampietro et aI., 1992 , 1997 On odera et aI., 1989; Zhang et aI., 1997) . Although dentate granule cell activation mediates ischemic CA 1 and hilar cell loss (Johansen et aI., 1986) , it is possible that de creased activation or down-regulation of dentate gluta- c E G mate receptors is the stimulus for increased neurogenesis after ischemic and other types of chronic hippocampal injury.
Neurogenesis also occurs after ischemia-induced isch emic tolerance in which there is no death of CA I neurons (Liu et aI., 1998) . However, there is death of dentate hilar neurons, even in the ischemia-induced tolerance model (Johansen et aI., 1987 (Johansen et aI., , 1993 Sugimoto et aI., 1993; Ben veniste and Diemer, 1988) , that provide significant input to dentate granule cells (Sugimoto et aI., 1993; Johansen, 1993) . This could decrease dentate glutamate receptor activation, through hilar interneurons, and trigger dentate neurogenesis in ischemic tolerant animals. Notably, NMDA but not AMP A receptors appear to mediate isch emia-induced tolerance (Bond et aI., 1999) , whereas both glutamate receptors modulate neurogenesis in normal and ischemic hippocampus.
Seizure-induced neurogenesis also could be related to cell death and glutamate receptor down-regulation, be cause the generalized seizures produced by pilocarpine produce death of CA3 neurons (Parent et aI., 1997) . Sei zure-induced neurogenesis caused by kainate (Gray and Sundstrom, 1998) is associated with CA3 (and CA I)
death that likely leads to chronic decreased activation of hippocampal glutamate receptors. Entorhinal cortical le sions (Cameron et aI., 1995) and granule cell lesions that stimulate neurogenesis (Gould and Tanapat, 1997) should decrease dentate glutamate receptor activation. MK-80 I or NBQX given systematically would obvi ously decrease stimulation of hippocampal glutamate re ceptors (Gould et aI., 1994; Cameron et aI., 1995) . Ad ministration of MK-80 I or NBQX before ischemia in the current study would prevent the death of neurons that occurs after ischemia, would maintain normal hippocam pal activity, and therefore would prevent ischemia induced decreases of glutamate receptor activation and increases of dentate neurogenesis. Pharmacologic blockade of NMDA R -dependent pro cesses with MK-80 1 decreases long-term stabilization of hippocampal activity (Zhang et aI., 1997; Kentros et aI., 1998) . Blockade of AMPA and Kainate receptors with NBQX also affects neurotransmission and plasticity in hippocampus (Chittajallu et aI., 1999; Vignes and Col Iingridge, 1997) . Long-term stabilization of firing fields in the hippocampus is required for normal glutamatergic function and related glutamatergic-dependent processes (Kentros et aI., 1998; Bertram and Zhang, 1999) . Modi fications of glutamatergic conductance produced by glu tamate antagonists or lesions of entorhinal cortex, amyg dala, dentate, CA3, or CAl could provoke long-term changes in glutamatergic neurotransmission and gluta mate receptors in the hippocampus with subsequent changes of the rates of dentate neurogenesis. This con trasts with the SVZs in which ischemia and glutamate receptor antagonists (data not shown) do not appear to modulate neurogenesis (Liu et aI., 1998; Doetsch et aI., 1999a,b) .
Considerable evidence indicates that Ca 2 + permeable AMP A R and NMDA R are critical mediators of global ischemia-induced death of CA l neurons (Simon et aI., 1984; Sheardown et aI., 1990; Diemer et aI., 1993; Mel drum, 1995; Colbourne et aI., 1999; Hicks et aI., 1999) . Some previous studies showed CA I protection with sys temic drugs (Gill and Woodruff, 1990; Warner et aI., 1991) and others did not (Buchan et aI., 1991a,b) . The current study supports some protective effects of MK-801 against global ischemic injury when given directly into hippocampus (Simon et aI., 1984) .
Blockade of AMP A/KA R also protects CA I pyramidal neurons against injury produced by global ischemia (Sheardown et a!., 1990; Diemer et aI., 1992; Buchan et aI., 199 Ia,b) . The current study supports a primary role for hippocampal AMP A/KA R because both systemic and intrahippocampal NBQX protected against CAl cell death after global ischemia. Recent studies indicate pos sible mechanisms of injury. NR2A and NR2B subunits of NMDA R , and GluR2 and GluR4 subunits of AMP A R decrease at early times after reperfusion in CA I pyrami dal cells perhaps producing changes of ion flux that me diate selective neuronal cell death after global ischemia (Pellegrini-Giampietro et aI., 1992; Gorter et a!., 1997; Ying et aI., 1997; Zhang et aI., 1997) . Results confirm that synapsin-l increases in the mossy fiber layer of the CA3 region of hippocampus after glob al ischemia (Marti et aI., 1999) and show that NMDA R and AMPA/KA R antagonists prevent synapsin-I induc tion. Stimuli for the CA3 synapsin up-regulation are un certain, but could be similar to those that stimulate neu rogenesis after ischemia.
Synapsin-l is a presynaptic protein involved in neuro transmitter release and regulation of axonal elongation and new synapse formation (Greengard et aI., 1993; Fer reira et aI., 1996) , synapsin-I phosphorylation releasing presynaptic vesicles from the reserve pool (Turner et aI., 1999) . Synapsin-I up-regulation in the CA3 region of the hippocampus after global ischemia suggests that it is induced in the presynaptic terminals of mossy fibers from dentate granule cell neurons that synapse on CA3 pyramidal neurons. This suggests altered synaptic func tion or formation of new synapses, or both, by granule cell mossy fibers on CA3 pyramidal neurons. The stimu lus for increased synapsin-I expression in dentate granule cell neuron mossy fibers could be death of some granule cell neurons with sprouting of their neighbors, or death of CA3 target neurons with synaptic reorganization of mossy fiber afferents onto surviving CA3 neurons, or both (Fukuda et aI., 1999; Hsu and Buzsaki, 1993; Li et aI., 1997; Onodera et aI., 1990 Onodera et aI., , 1993 . Thus, MK-80 l and NBQX may prevent synapsin-I induction simply by preventing ischemia-induced cell death.
The synapsin-l induction probably occurs mainly in granule cell neurons that project to CA3. Because cell proliferation does not begin until 7 days after ischemia (Liu et aI., 1998) , and because newborn granule cells with neuronal phenotypes are not detected until 1 to 3 weeks after ischemia (Liu et aI., 1998) , the synapsin-I induction at 7 and 15 days is probably not due to syn aptogenesis of neurons born after ischemia. At later times it is possible that newborn granule cell neurons contribute to mossy fiber synaptogenesis in CA3 because newborn neurons extend axons to CA3 (Stanfield and Trice, 1988; Markakis and Gage, 1999) . The suppression of neurogenesis and synaptogenesis by glutamate recep tor activation and its enhancement by NMDA R and AMP A/KA R inactivation, may provide a means whereby natural alterations in the degree of excitatory input con trol the numbers of newborn neurons and the sprouting of existing neurons.
